Samlyn Capital’s Exelixis EXEL Stock Holding History

Samlyn Capital’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,209,900	Closed	-$29M	–	102
2023 Q4	$29M	Buy	1,209,900 +710,600	+142%	+$15.4M	0.58%	48
2023 Q3	$10.9M	Buy	+499,300	New	+$10.4M	0.18%	82

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Samlyn Capital's EXEL Position: Q3 2020 in Review

Samlyn Capital sold out of Exelixis (EXEL) in Q3 2020, closing a stake of 1,011,903 shares — an estimated $24M sold.

Samlyn Capital first reported a position in EXEL in Q4 2018 and held it in 4 quarters. The position peaked at $24M in Q2 2020. 367 funds tracked by Wall St. Rank hold EXEL as of Q3 2020.

Samlyn Capital reported no remaining Exelixis position as of Q3 2020 after selling out during the quarter.
Samlyn Capital sold 1,011,903 Exelixis shares in Q3 2020, an estimated $24M.
Samlyn Capital first reported a position in Exelixis in Q4 2018 and held it in 4 quarters.
Samlyn Capital's Exelixis position peaked at $24M in Q2 2020.
367 funds tracked by Wall St. Rank held Exelixis as of Q3 2020.

Based on Samlyn Capital's 13F filing for Q3 2020, filed 16 Nov 2020.